Supply Of Coronary Drug Eluting Stents With ( 1 ) Stent On Cobalt Chromium Alloy Or Platinum Chromium Alloy......Unit-Nocoronary Drug Eluting Stents With ( 1 ) Stent On Cobalt Chromium Alloy Or Platinum Chromium Alloy......Unit-No, Coronary Drug Eluti
Tender Overview
Project Description
Supply Of Coronary Drug Eluting Stents With ( 1 ) Stent On Cobalt Chromium Alloy Or Platinum Chromium Alloy......Unit-Nocoronary Drug Eluting Stents With ( 1 ) Stent On Cobalt Chromium Alloy Or Platinum Chromium Alloy......Unit-No, Coronary Drug Eluting Stents With ( 1 ) Stent On Cobalt Chromium Alloy Or Platinum Chromium Alloy. ( 2 ) Stent With Coating Of Polymer Carrier For Active Drug ( Sirolimus, Everolimus Or Zotarolimus Shown To Be Effective In Preventing Neo-Intimal Hyperplasia ) ( 3 ) Stent Diameter Should Be From 2.5Mm To 4Mm . The Length Of The Stent Should Be More Than 38Mm . ( 4 ) The Strut Thickness Should Be 91 Micron Or Less. ( 5 ) Stent Delivery System Should Be Monorail ( Single Operator Exchange Or Rapid Exchange ) . ( 6 ) Stent Should Be Compatible With 5Fr Guiding Catheter ( 7 ) Stent Design Should Be Open Cell Type. ( 8 ) Stent Should Be Approved By Dcgi. The Copy Of Dcgi Approval Should Be Enclosed In The Tender Bid / Offer. ( 9 ) The Long Term Efficacy And Safety Of The Stent, The Rates Of In-Stent Restenosis ( Isr ) And In-Situ Thrombosis ( Ist ) Should Be Documented / Published In Peer Reviewed Scientific Journals. ( 10 ) The Manufacturer / Supplier Should Submit Proof Of Supply Of The Stent To A Major Government Institute.Bis Standards For The Drug Eluting Stent Are Not Available ( Reference : Bis Catalogue ) Unit-No
BOQ
| Sl. No. | Item Description |
| 1 | CORONARY DRUG ELUTING STENTS WITH (1) STENT ON COBALT CHROMIUM ALLOY OR PLATINUM CHROMIUM ALLOY......UNIT-NO |
| 2 | CORONARY DRUG ELUTING STENTS WITH (1) STENT ON COBALT CHROMIUM ALLOYOR PLATINUM CHROMIUM ALLOY. (2) STENT WITH COATING OF POLYMER CARRIER FOR ACTIVEDRUG ( SIROLIMUS, EVEROLIMUS OR ZOTAROLIMUS SHOWN TO BE EFFECTIVE IN PREVENTINGNEO-INTIMAL HYPERPLASIA) (3) STENT DIAMETER SHOULD BE FROM 2.5MM TO 4MM . THE LENGTHOF THE STENT SHOULD BE MORE THAN 38MM . (4) THE STRUT THICKNESS SHOULD BE 91 MICRONOR LESS. (5) STENT DELIVERY SYSTEM SHOULD BE MONORAIL (SINGLE OPERATOR EXCHANGE ORRAPID EXCHANGE). (6) STENT SHOULD BE COMPATIBLE WITH 5FR GUIDING CATHETER (7) STENTDESIGN SHOULD BE OPEN CELL TYPE. (8) STENT SHOULD BE APPROVED BY DCGI. THE COPY OFDCGI APPROVAL SHOULD BE ENCLOSED IN THE TENDER BID / OFFER. (9) THE LONG TERMEFFICACY AND SAFETY OF THE STENT, THE RATES OF IN-STENT RESTENOSIS (ISR) AND IN-SITUTHROMBOSIS (IST) SHOULD BE DOCUMENTED / PUBLISHED IN PEER REVIEWED SCIENTIFICJOURNALS. (10)THE MANUFACTURER/SUPPLIER SHOULD SUBMIT PROOF OF SUPPLY OF THESTENT TO A MAJOR GOVERNMENT INSTITUTE.BIS STANDARDS FOR THE DRUG ELUTING STENTARE NOT AVAILABLE (REFERENCE : BIS CATALOGUE ) UNIT-NO |
AI Tender Summary
Tender Timeline
Tender Published
Tender notice published.
CompletedBid Submission Deadline
Online submission via eProcurement portal.
Completed